Anthropic Inc. Officially Launches IPO Roadshow by October 31, 2026 for Nasdaq Listing (Confirmed by Anthropic Press Release or Reuters by November 1, 2026)
Pending
✦ AI-generated prediction
Published on 26. September 2026
·
Predicted for 31. October 2026
·
Based on: Speculative
Anthropic filed its confidential S-1 with the SEC in June 2026. Reuters reported on September 5, 2026 that roadshow marketing is set to begin mid-October 2026, with the first trading day a few days before the US midterms (November 3, 2026). The expected valuation of ~$2 trillion would surpass SpaceX as the largest-ever IPO. Polymarket sees 56.8% probability for Anthropic as the largest 2026 IPO by market cap. With the S-1 already filed and a concrete timeline in place, the probability of a formal roadshow launch by October 31 is ~76% — above the Polymarket anchor — as only extraordinary market turbulence or regulatory objections would force a delay into November.
Data basis for this prediction
- CNBC (05.09.2026): Anthropic IPO Roadshow-Start Mitte Oktober geplant, Handel vor US-Midterms
- Fortune (13.08.2026): Anthropic ~$2-Billionen-IPO im Oktober, potenziell größter IPO aller Zeiten
- Polymarket: Anthropic = wahrscheinlichster größter 2026-IPO nach Market Cap (56,8 %, Stand 25.09.2026)
- Anthropic: Vertrauliches S-1 bei SEC eingereicht (Juni 2026, bestätigt durch Reuters)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
💻 Technology
✦ AI
Jens Juul Holst (University of Copenhagen), Svetlana Mojsov (Rockefeller University) and Daniel J. Drucker (Lunenfeld-Tanenbaum Research Institute, Toronto) were named Clarivate Citation Laureates 2026 on September 17, 2026 for GLP-1 foundational research — the basis for semaglutide (Ozempic/Wegovy) and tirzepatide. Lotte Bjerre Knudsen (Novo Nordisk) is cited as pharmacological complement. GLP-1 is rated the leading candidate field for the 2026 Medicine Nobel by medium.com and oneseventynine.ai. With ~15 competing candidate constellations, single-field probability is approximately 20–25%; no dedicated Polymarket market available.
💻 Technology
✦ AI
Google has launched a new Pixel flagship every year since 2017: Pixel 7 (Oct 2022), Pixel 8 (Oct 2023), Pixel 9 (Aug 2024), Pixel 10 (Oct 2025). The Pixel 11 Pro for October 2026 continues this cycle; leaks regarding an upgraded Tensor G6 (or Snapdragon X Elite equivalent) and expanded on-device Gemini capabilities have circulated since August 2026. No specific prediction market found; own estimate based on the annual release pattern and the assumption that the Pixel 9/10/11 cycle continues yearly. Main risk: event shifted to November 2026 (~15%) or unexpected rebrand. Forecast: 75% by October 31.
💻 Technology
✦ AI
Tesla traditionally releases quarterly figures in the first business days of the following quarter (approx. October 2, 2026 for Q3). Q3 2024 deliveries were 462,890 vehicles. With the ongoing Cybercab ramp-up, refreshed Juniper Model Y, and stable China/US deliveries, Bloomberg consensus for Q3 2026 estimates approximately 470,000–520,000 units. The 480,000 threshold represents ~3.7% growth vs. Q3 2024 and sits in the lower half of the consensus range — ambitious enough to be informative. Headwinds: Fed rates at 3.75–4.00% dampen vehicle demand; BYD intensifies China competition. No direct Polymarket market available; own calibration: 57%.